Modulatory effect of Inula racemosa Hook. f. (Asteraceae) on experimental atherosclerosis in guinea-pigs

Journal of Pharmacy and Pharmacology

Volumn 61, Issue 8, 2009, Pages 1111-1118

  Mangathayaru, Kalachaveedu ^a   Kuruvilla, Sarah ^a   Balakrishna, Kedike ^b   Venkhatesh, Jayakothandaramaswamy ^a  

^a SRI RAMACHANDRA UNIVERSITY   (India)

^b Captain Srinivasamurthy Drug Research Institute for Ayurveda Chennai   (India)

Author keywords

Anti obesity; Antioxidant; Atheroprotective; Hypolipidaemic; Inula racemosa

Indexed keywords

ATORVASTATIN; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INULA RACEMOSA EXTRACT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHENOL DERIVATIVE; PLANT EXTRACT; SESQUITERPENE DERIVATIVE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; CHOLESTEROL; SOLVENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY; DRUG EFFECT; GUINEA PIG; HISTOPATHOLOGY; INULA; INULA RACEMOSA; LIPID BLOOD LEVEL; LIPID DIET; MALE; NONHUMAN; WEIGHT GAIN; ANIMAL; AYURVEDA; BLOOD; BODY WEIGHT; CHEMISTRY; CORONARY BLOOD VESSEL; DISEASE MODEL; FAT INTAKE; METABOLISM; PATHOLOGY;

ANIMALS; AORTA; ATHEROSCLEROSIS; BODY WEIGHT; CHOLESTEROL; CORONARY VESSELS; DIETARY FATS; DISEASE MODELS, ANIMAL; GUINEA PIGS; INULA; MALE; MEDICINE, AYURVEDIC; PLANT EXTRACTS; SOLVENTS; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 70249114091     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp/61.08.0016     Document Type: Article

References (40)

1. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-124.
2. Ling WH et al. Red and black rice decrease atherosclerotic plaque formation and increased antioxidant status in rabbits. J Nutr 2001; 131: 1421-1426.
3. Mohammed H, Moghadasian D. Experimental atheroscerosis - a historical overview. Life Sci 2002; 70: 855-856.
4. Williamson EM. Synergy in relation to the pharmacological action of phytomedicinals. In: Evans WC, Daphne TE, eds. Trease and Evans Pharmacognosy, 15th edn. London: Harcourt, 2002: 49-54.
5. Charak. Charak Samhita, 3rd edn. Mumbai: Nirnaya Sagar Press, 1941.
6. Arora RK et al. Mano (Inula racemosa): little known aromatic plant of Lahaul valley, India. Econ Botany 1980; 34: 175-180.
7. Singh R et al. Pushkara-guggulu an anti anginal and hypolipidaemic agent in coronary heart disease. J Res Ayur Siddha 1990; 12: 1-18.
8. Tripathy YB et al. Assessment of adrenergic beta blocking activity of Inula racemosa. J Ethnopharmacol 1988; 23: 3-9.
9. Dwivedi S et al. Influence of certain indigenous drugs on prostaglandin E2 like activity in the ischaemic rabbit aorta. Ind Drugs 1987; 24: 8-10.
10. Tripathy SN et al. Beneficial effect of Inula racemosa (Pushkarmoola) in angina pectoris: a preliminary report. Ind J Physiol Pharmacol 1984; 28: 73-75.
11. Gholaps S, Kar A. Effects of Inula racemosa and Gymnema sylvestre leaf extracts in the regulation of corticosteroid induced diabetes mellitus: involvement of thyroid hormones. Pharmazie 2003; 58: 413-415.
12. Sekhar AV et al. An experimental and clinical evaluation of anti asthmatic potential of Devadaru compound (DC). Ind J Physiol Pharmacol 2003; 47: 101-107.
13. Rao KS, Mishra SH. Hepatoprotective activity of Inula racemosa root. Fitoterapia 1997; 68: 510-514.
14. NISCAIR. Wealth of India, Raw Materials. New Delhi: National Institute of Science Communication and Information Resources, 2002.
15. Milman IA. Alanto and isoalantolactones. Khimiya Prirodnykh Soedinenii 1990; 3: 307-320.
16. Hall IH et al. Mode of action of sesquiterpene lactones as anti inflammatory agents. J Pharm Sci 1980; 69: 537-543.
17. Rath M, Pauling L. Immunological evidence for the accumulation of lipoprotein (a) in the atherosclerotic lesion of the hypoascorbic guinea pig. Proc Natl Acad Sci USA 1990; 87: 9388-9390.
18. Fernandez ML. Guinea pigs as models for cholesterol and lipoprotein metabolism. J Nutr 2001; 131: 10-20.
19. Slinkard K, Singleton VL. Total phenol analysis: automaton and comparison with manual methods. Am J Enol Vitic 1977; 28: 49.
20. Freidwal WT et al. Estimation of the concentration of low density lipoprotein-C without the use of ultracentrifuge. Clin Chem 1992; 18: 499-502.
21. Yoon NY et al. Anti-hyperlipidaemic effect of an edible brown algae, Ecklonia stolonifera, and its constituents on poloxamer 407-induced hyperlipidaemic and cholesterol fed rabbits. Arch Pharm Res 2008; 31: 1564-1571.
22. Okhawa H et al. Assay of lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-358.
23. Moran MS et al. Levels of glutathione reductase and glutathione S transferase activities in rats' lung and liver. Biochim Biophys Acta 1979; 582: 67-78.
24. Poonam K et al. A modified spectrophotometric assay of super oxide dismutase. Ind J Biochem Biophys 1984; 21: 130-132.
25. Rotruck JT et al. Selenium: biochemical roles as a component of glutathione peroxidase. Science 1973; 179: 588-590.
26. Lowry OH et al. Protein measurement with Folin phenol reagent. J Biol Chem 1951; 193: 265-275.
27. Efendy JL et al. The effect of aged garlic extract 'kyolic' on the development of experimental atheroscerosis. Atherosclerosis 1997; 132: 37-42.
28. Malinow MW et al. Effect of alfalfa meal on shrinkage of atherosclerotic plaque during cholesterol feeding in monkeys. Atherosclerosis 1978; 30: 27-43.
29. Russel R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-125.
30. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 1997; 272: 20 963-20 966.
31. Morel DW et al. Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid. J Lipid Res 1983; 24: 1070-1076.
32. Navab M et al. The yin and yang of oxidation in the development of the fatty streak: a review based on the 1994 George Lyman Duff Memorial Lecture. Arterioscler Thromb Vasc Biol 1996; 16: 831-842.
33. Chang MY et al. Inhibition of hypercholesterolemia induced atherosclerosis in the non human primate by probucol II. Cellular composition and proliferation. Arterioscler Thromb Vasc Biol 1995; 15: 1631-1640.
34. Fruebis J et al. Effect of probucol treatment on gene expression of VCAM- 1, MCP-1 and M-CSF in the aortic wall of LDL receptor deficient rabbits during early atherogenesis. Arterioscler Thromb Vasc Biol 1997; 17: 1289-1302.
35. Reaven PD et al. Effect of dietary antioxidant combinations in humans: protection of LDL by vitamin E but not by beta carotene. Arterioscler Thromb Vasc Biol 1993; 13: 590-600.
36. Baum BO, Perun AL. Anti oxidant efficiency versus structure. Soc Plast Eng Trans 1962; 2: 250-257.
37. Mangiapane H et al. The inhibition of the oxidation of low density lipoprotein by (+) catechin - a naturally occurring flavonoid. Biochem Pharmacol 1992; 43: 445-450.
38. Setchell KDR et al. Lignan formation in man. Lancet 1981; i: 4-7.
39. Hodgson JM et al. Soybean isoflavonoids and their metabolic products inhibit in vitro lipoprotein metabolism. J Nutr Biochem 1996; 7: 664-669.
40. Arnal JF et al. Ethinyl estradiol does not enhance the expression of nitric oxide synthase in bovine endothelial cells but increases the release of bioactive nitric oxide by inhibiting super oxide anion production. Proc Natl Acad Sci USA 1996; 93: 4108-4113.